Pulmonx Corporation (LUNG) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 89.92M |
| Enterprise Value | 76.27M |
| P/E Ratio | -1.42 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 0.79 |
| Price/Book Ratio | 1.75 |
| Enterprise/Revenue | 0.79 |
| Enterprise/EBITDA | -1.61 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.55 |
| Operating Margin | -0.53 |
| Return On Assets | -0.42 |
| Return On Equity | -0.97 |
| Revenue | 90.5M |
| Revenue/Share | 2.07 |
| Gross Profit | 67.14M |
| EBITDA | -49.17M |
| Net Income | -54M |
| Diluted EPS | -1.33 |
| Total Cash | 55.84M |
| Total Cash/Share | 1.32 |
| Total Debt | 56.21M |
| Total Debt/Equity | 1.43 |
| Current Ratio | 4.32 |
| Book Value Per Share | 0.93 |
| 52-Week Change | -1.21 |
| 52-Week High | 2.89 |
| 52-Week Low | 1.13 |
| Moving Average 50 Days | 1.42 |
| Moving Average 200 Days | 1.61 |
| Average Volume | 521,272 |
| Shares Outstanding | 42.24M |
| % Held by Institutions | 75.78 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |